is a recently discovered peptide with structural similarity to known natriuretic peptides. DNP has been shown to possess potent renal actions. Our objectives were to define the acute hemodynamic actions of DNP in normal anesthetized dogs and the acute effects of DNP on left ventricular (LV) function in conscious chronically instrumented dogs. In anesthetized dogs, DNP, but not placebo, decreased mean arterial pressure (141 Ϯ 6 to 109 Ϯ 7 mmHg, P Ͻ 0.05) and pulmonary capillary wedge pressure (5.8 Ϯ 0.3 to 3.4 Ϯ 0.2 mmHg, P Ͻ 0.05). Cardiac output decreased and systemic vascular resistance increased with DNP and placebo. DNP-like immunoreactivity and guanosine 3Ј,5Ј-cyclic monophosphate concentration increased without changes in other natriuretic peptides. In conscious dogs, DNP decreased LV end-systolic pressure (120 Ϯ 7 to 102 Ϯ 6 mmHg, P Ͻ 0.05) and volume (32 Ϯ 6 to 28 Ϯ 6 ml, P Ͻ 0.05) and LV end-diastolic volume (38 Ϯ 5 to 31 Ϯ 4 ml, P Ͻ 0.05) but not arterial elastance. LV end-systolic elastance increased (6.1 Ϯ 0.7 to 7.4 Ϯ 0.6 mmHg/ml, P Ͻ 0.05), and Tau decreased (31 Ϯ 2 to 27 Ϯ 1 ms, P Ͻ 0.05). The effects on hemodynamics, LV function, and second messenger generation suggest synthetic DNP may have a role as a cardiac unloading and lusitropic peptide. natriuretic peptides; systolic function; diastolic function DENDROASPIS NATRIURETIC PEPTIDE (DNP) is a recently discovered 38-amino acid peptide, isolated from the Dendroaspis augusticeps snake, with structural similarity to atrial, brain, and C-type natriuretic peptide (ANP, BNP, and CNP) (4, 18). DNP-like immunoreactivity has been reported in human atria and plasma and is increased in the plasma of patients with congestive heart failure (17). Recently, DNP-like immunoreactivity has been reported in canine plasma and myocardium, and synthetic DNP has been shown to be markedly natriuretic in dogs (10). Indeed, the potent renal actions of synthetic DNP suggest its potential use in the treatment of cardiovascular disease states such as congestive heart failure.The natriuretic peptides have natriuretic and vasodilating properties that are mediated by the second messenger guanosine 3Ј,5Ј-cyclic monophosphate (cGMP). Studies with synthetic DNP to date indicate that it, too, produces natriuresis, causes relaxation in rodent aorta and rodent and canine coronary arteries, and augments formation of cGMP from aortic endothelial cells (4,18). Most recently, we demonstrated that the natriuretic peptides possess direct inotropic and lusitropic myocardial actions in the dog (9, 24). However, the effects of synthetic DNP on systemic hemodynamics and left ventricular (LV) function in vivo are poorly defined.The aim of the current study was to observe the acute in vivo effects of synthetic DNP on systemic hemodynamics and LV function in normal dogs. We hypothesized that exogenously infused synthetic DNP would result in reductions in preload and afterload, together with improvements in ventricular systolic and diastolic function in normal dogs.
METHODSExperiments were perfo...